Fortress Biotech Correlations
FBIO Stock | USD 2.13 0.30 16.39% |
The current 90-days correlation between Fortress Biotech and Achilles Therapeutics PLC is -0.17 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fortress Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fortress Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Fortress Biotech Correlation With Market
Modest diversification
The correlation between Fortress Biotech and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech and DJI in the same portfolio, assuming nothing else is changed.
Fortress |
Moving together with Fortress Stock
Moving against Fortress Stock
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Fortress Stock performing well and Fortress Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fortress Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MBIO | 3.76 | (0.36) | 0.00 | 0.56 | 0.00 | 7.14 | 41.50 | |||
ACHL | 1.97 | 0.52 | 0.23 | 0.51 | 1.39 | 3.06 | 38.16 | |||
APTO | 3.56 | (0.99) | 0.00 | 1.39 | 0.00 | 5.41 | 33.33 | |||
FBIOP | 2.27 | (0.20) | 0.00 | (0.14) | 0.00 | 3.60 | 16.27 | |||
CKPT | 3.20 | 1.07 | 0.26 | 3.51 | 3.09 | 7.91 | 19.17 | |||
ATXI | 3.20 | (0.15) | 0.00 | 1.76 | 0.00 | 6.81 | 23.22 | |||
PIRS | 1.58 | (0.14) | 0.00 | (0.11) | 0.00 | 3.23 | 12.92 | |||
ALRN | 4.31 | 0.42 | 0.06 | 2.32 | 4.65 | 8.06 | 41.47 | |||
RVPHW | 14.03 | 3.17 | 0.16 | (6.66) | 15.22 | 28.57 | 129.53 | |||
EYEN | 6.68 | (1.77) | 0.00 | (0.46) | 0.00 | 14.29 | 92.81 |
Fortress Biotech Corporate Management
George Avgerinos | Sr. VP of Biologics Operations | Profile | |
Samuel Berry | General Secretary | Profile | |
Robyn Hunter | Ex Officer | Profile | |
Thomas Schaible | Project Disease | Profile |